{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:03:41Z","timestamp":1787972621293,"version":"build-2784847793"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In May 2022, a new global outbreak of mpox (formerly,\u00a0human monkeypox)\u00a0emerged that was declared a public health emergency of international concern by the World Health Organization on July 23, 2022. With new patterns of person-to-person spread within sexual networks in nonendemic countries and several differences from the classic disease course, we performed a comprehensive review of existing literature on human monkeypox to discuss epidemiology, modes of transmission, clinical presentation and asymptomatic infection, diagnostics, therapeutics, and vaccines with the primary aim to identify important areas for future research of this new epidemic form of the disease.\u00a0A comprehensive literature search was performed of all published literature to August 15, 2022.\u00a0Historically, in regions of monkeypox virus endemicity, human outbreaks have occurred related to discrete zoonotic events. The animal reservoir is unknown, but the virus has been isolated from rodents. Traditionally, transmission occurred by direct or indirect contact with an infected animal. In nonendemic countries affected in the 2022 outbreak, almost exclusive person-to-person spread has been observed, and most cases are connected to sexual networks of gay, bisexual, and other men who have sex with men. After an incubation period of approximately 13 days, in traditional human cases affected persons developed a febrile prodrome preceding a rash that started on the face and body, spread centrifugally to the palms and soles and healed monomorphically over two to four weeks. However, in the 2022 outbreak, the febrile illness is often absent or occurs after the onset of the rash. The rash presents primarily in the anogenital region and face before disseminating throughout the body, with lesions displaying regional pleomorphism. There is a paucity of data for the role of antiviral agents or vaccines.\u00a0The epidemiology and clinical course of mpox has changed in the 2022 epidemic from that observed with the endemic disease. There is an urgent need to establish rapid and collaborative research platforms to diagnose, treat and prevent disease and inform important public health and other strategies to stop the spread of disease.<\/jats:p>","DOI":"10.1186\/s12879-022-07900-7","type":"journal-article","created":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T22:02:42Z","timestamp":1670796162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2744-6152","authenticated-orcid":false,"given":"Sharon","family":"Sukhdeo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmistha","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Walmsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"7900_CR1","doi-asserted-by":"crossref","unstructured":"Happi C, Adetifa I, Mbala P, Njouom R, et al. Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus - Monkeypox [Internet]. Virological. 2022 [cited 2022 Aug 10]. Available from: https:\/\/virological.org\/t\/urgent-need-for-a-non-discriminatory-and-non-stigmatizing-nomenclature-for-monkeypox-virus\/853.","DOI":"10.1371\/journal.pbio.3001769"},{"issue":"2","key":"7900_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3201\/eid2502.181222","volume":"25","author":"RH Doshi","year":"2019","unstructured":"Doshi RH, Guagliardo SAJ, Doty JB, Babeaux AD, Matheny A, Burgado J, et al. Epidemiologic and ecologic investigations of Monkeypox, Likouala Department, Republic of the Congo, 2017. Emerg Infect Dis. 2019;25(2):273\u201381.","journal-title":"Emerg Infect Dis"},{"issue":"8472","key":"7900_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0140-6736(86)90748-8","volume":"11","author":"L Khodakevich","year":"1986","unstructured":"Khodakevich L, Jezek Z, Kinzanzka K. Isolation of monkeypox virus from wild squirrel infected in nature. Lancet Lond Engl. 1986;11(8472):98\u20139.","journal-title":"Lancet Lond Engl"},{"issue":"6","key":"7900_CR4","first-page":"747","volume":"66","author":"L Khodakevich","year":"1988","unstructured":"Khodakevich L, Jezek Z, Messinger D. Monkeypox virus: ecology and public health significance. Bull World Health Organ. 1988;66(6):747\u201352.","journal-title":"Bull World Health Organ"},{"issue":"2","key":"7900_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1699-0463.1959.tb00328.x","volume":"46","author":"P Von Magnus","year":"1959","unstructured":"Von Magnus P, Andersen EK, Petersen KB, Birch-Andersen A. A pox-like disease in cynomolgus monkeys. Acta Patholog Microbiolog Scand. 1959;46(2):156\u201376.","journal-title":"Acta Patholog Microbiolog Scand"},{"issue":"1","key":"7900_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/br.37.1.1-18.1973","volume":"37","author":"CT Cho","year":"1973","unstructured":"Cho CT, Wenner HA. Monkeypox virus. Bacteriol Rev. 1973;37(1):1\u201318.","journal-title":"Bacteriol Rev"},{"issue":"5","key":"7900_CR7","first-page":"625","volume":"46","author":"I Arita","year":"1972","unstructured":"Arita I, Gispen R, Kalter SS, Wah LT, Marennikova SS, Netter R, et al. Outbreaks of monkeypox and serological surveys in nonhuman primates. Bull World Health Organ. 1972;46(5):625\u201331.","journal-title":"Bull World Health Organ"},{"key":"7900_CR8","first-page":"p1297","volume-title":"Smallpox and its eradication","author":"F Fenner","year":"1988","unstructured":"Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. Chapter 29\u2014\u00a0human monkeypox virus and other Poxvirus Infections of Man. In: Smallpox and its eradication. Geneva: World Health Organization; 1988. p. p1297."},{"issue":"9","key":"7900_CR9","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1056\/NEJMc060792","volume":"31","author":"IK Damon","year":"2006","unstructured":"Damon IK, Roth CE, Chowdhary V. Discovery of monkeypox in Sudan. N Engl J Med. 2006;31(9):962\u20133.","journal-title":"N Engl J Med"},{"issue":"2","key":"7900_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3201\/eid1902.121220","volume":"19","author":"Y Nakazawa","year":"2013","unstructured":"Nakazawa Y, Emerson GL, Carroll DS, Zhao H, Li Y, Reynolds MG, et al. Phylogenetic and ecologic perspectives of a monkeypox outbreak, southern Sudan, 2005. Emerg Infect Dis. 2013;19(2):237\u201345.","journal-title":"Emerg Infect Dis"},{"key":"7900_CR11","unstructured":"World Health Organization. Global Commission for the Certification of Smallpox Eradication. Organization WH. The global eradication of smallpox: final report of the Global Commission for the Certification of Smallpox Eradication, Geneva, December 1979 [Internet]. World Health Organization; 1980 [cited 2022 Aug 7]. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/39253."},{"issue":"2","key":"7900_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/infdis\/156.2.293","volume":"156","author":"Z Jezek","year":"1987","unstructured":"Jezek Z, Szczeniowski M, Paluku KM, Mutombo M. Human monkeypox: clinical features of 282 patients. J Infect Dis. 1987;156(2):293\u20138.","journal-title":"J Infect Dis"},{"issue":"4","key":"7900_CR13","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1056\/NEJMoa032299","volume":"22","author":"KD Reed","year":"2004","unstructured":"Reed KD, Melski JW, Graham MB, Regnery RL, Sotir MJ, Wegner MV, et al. The detection of monkeypox in humans in the western hemisphere. N Engl J Med. 2004;22(4):342\u201350.","journal-title":"N Engl J Med"},{"issue":"6","key":"7900_CR14","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1086\/505880","volume":"194","author":"MG Reynolds","year":"2006","unstructured":"Reynolds MG, Yorita KL, Kuehnert MJ, Davidson WB, Huhn GD, Holman RC, et al. Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis. 2006;194(6):773\u201380.","journal-title":"J Infect Dis."},{"issue":"6","key":"7900_CR15","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/oxfordjournals.aje.a114747","volume":"126","author":"Z Jezek","year":"1987","unstructured":"Jezek Z, Grab B, Dixon H. Stochastic model for interhuman spread of monkeypox. Am J Epidemiol. 1987;126(6):1082\u201392.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"7900_CR16","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/ije\/17.3.643","volume":"17","author":"PE Fine","year":"1988","unstructured":"Fine PE, Jezek Z, Grab B, Dixon H. The transmission potential of monkeypox virus in human populations. Int J Epidemiol. 1988;17(3):643\u201350.","journal-title":"Int J Epidemiol"},{"key":"7900_CR17","unstructured":"Morbidity and Mortality Weekly Report Vol52 (27). CDC; 2003."},{"key":"7900_CR18","unstructured":"CDC. Monkeypox in the U.S. - World Map [Internet]. Centers for Disease Control and Prevention. 2022 [cited 2022 Aug 14]. Available from: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/response\/2022\/world-map.html."},{"issue":"3","key":"7900_CR19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1473-3099(18)30043-4","volume":"18","author":"O Faye","year":"2018","unstructured":"Faye O, Pratt CB, Faye M, Fall G, Chitty JA, Diagne MM, et al. Genomic characterisation of human monkeypox virus in Nigeria. Lancet Infect Dis. 2018;18(3):246.","journal-title":"Lancet Infect Dis."},{"key":"7900_CR20","unstructured":"Monkeypox. \u2013 Nigeria [Internet]. [cited 2022 Oct 31]. Available from: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/05-october-2018-monkeypox-nigeria-en."},{"issue":"8","key":"7900_CR21","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/S1473-3099(19)30294-4","volume":"19","author":"A Yinka-Ogunleye","year":"2019","unstructured":"Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y, et al. Outbreak of human monkeypox in Nigeria in 2017\u201318: a clinical and epidemiological report. Lancet Infect Dis. 2019;19(8):872\u20139.","journal-title":"Lancet Infect Dis."},{"key":"7900_CR22","unstructured":"WHO Director-General\u2019s statement at the press conference following IHR Emergency Committee regarding the multi-country outbreak of monkeypox \u2013 23 July 2022 [Internet]. [cited 2022 Aug 14]. Available from: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-statement-on-the-press-conference-following-IHR-emergency-committee-regarding-the-multi--country-outbreak-of-monkeypox--23-july-2022."},{"key":"7900_CR23","unstructured":"CDC. 2022 Monkeypox Outbreak Global Map [Internet]. Centers for Disease Control and Prevention. 2022 [cited 2022 Nov 4]. Available from: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/response\/2022\/world-map.html."},{"key":"7900_CR24","doi-asserted-by":"crossref","unstructured":"Isidro J, Borges V, Pinto M, Sobral D, Santos JD, Nunes A, et al. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nat Med. 2022.","DOI":"10.1038\/s41591-022-01907-y"},{"issue":"9","key":"7900_CR25","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1093\/molbev\/msq088","volume":"27","author":"C Firth","year":"2010","unstructured":"Firth C, Kitchen A, Shapiro B, Suchard MA, Holmes EC, Rambaut A. Using time-structured data to estimate evolutionary rates of double-stranded DNA viruses. Mol Biol Evol. 2010;27(9):2038\u201351.","journal-title":"Mol Biol Evol"},{"issue":"7","key":"7900_CR26","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/infdis\/jix260","volume":"216","author":"PK Mbala","year":"2017","unstructured":"Mbala PK, Huggins JW, Riu-Rovira T, Ahuka SM, Mulembakani P, Rimoin AW, et al. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo. J Infect Dis. 2017;216(7):824\u20138.","journal-title":"J Infect Dis."},{"issue":"5","key":"7900_CR27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1086\/427805","volume":"40","author":"AT Fleischauer","year":"2005","unstructured":"Fleischauer AT, Kile JC, Davidson M, Fischer M, Karem KL, Teclaw R, et al. Evaluation of human-to-human transmission of monkeypox from infected patients to health care workers. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005;40(5):689\u201394.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"4","key":"7900_CR28","doi-asserted-by":"publisher","first-page":"ofx168","DOI":"10.1093\/ofid\/ofx168","volume":"4","author":"E Nakoune","year":"2017","unstructured":"Nakoune E, Lampaert E, Ndjapou SG, Janssens C, Zuniga I, Van Herp M, et al. A nosocomial outbreak of human monkeypox in the central African Republic. Open Forum Infect Dis. 2017;4(4):ofx168.","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"7900_CR29","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3201\/eid2604.191164","volume":"26","author":"A Vaughan","year":"2020","unstructured":"Vaughan A, Aarons E, Astbury J, Brooks T, Chand M, Flegg P, et al. Human-to-human transmission of Monkeypox Virus, United Kingdom, October 2018. Emerg Infect Dis. 2020;26(4):782\u20135.","journal-title":"Emerg Infect Dis"},{"key":"7900_CR30","doi-asserted-by":"crossref","unstructured":"Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al. Monkeypox virus infection in humans across 16 Countries\u2014April\u2013June 2022. N Engl J Med. 2022.","DOI":"10.1056\/NEJMoa2207323"},{"issue":"27","key":"7900_CR31","first-page":"2200471","volume":"7","author":"JI Mart\u00ednez","year":"2022","unstructured":"Mart\u00ednez JI, Montalb\u00e1n EG, Bueno SJ, Mart\u00ednez FM, Juli\u00e1 AN, D\u00edaz JS, et al. Monkeypox outbreak predominantly affecting men who have sex with men, Madrid, Spain, 26 April to 16 June 2022. Eurosurveillance. 2022;7(27):2200471.","journal-title":"Eurosurveillance"},{"key":"7900_CR32","doi-asserted-by":"crossref","unstructured":"Lapa D, Carletti F, Mazzotta V, Matusali G, Pinnetti C, Meschi S, et al. Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding. Lancet Infect Dis [Internet]. 2022 Aug 2 [cited 2022 Aug 9];0(0). Available from: https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS14733099(22)00513-8\/fulltext.","DOI":"10.1016\/S1473-3099(22)00513-8"},{"issue":"12","key":"7900_CR33","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1086\/498115","volume":"15","author":"GD Huhn","year":"2005","unstructured":"Huhn GD, Bauer AM, Yorita K, Graham MB, Sejvar J, Likos A, et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005;15(12):1742\u201351.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"24","key":"7900_CR34","doi-asserted-by":"publisher","first-page":"2200448","DOI":"10.2807\/1560-7917.ES.2022.27.24.2200448","volume":"27","author":"F Miura","year":"2022","unstructured":"Miura F, van Ewijk CE, Backer JA, Xiridou M, Franz E, Op de Coul E, et al. Estimated incubation period for monkeypox cases confirmed in the Netherlands May, 2022. Eurosurveillance. 2022;27(24):2200448.","journal-title":"Eurosurveillance."},{"issue":"4","key":"7900_CR35","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/infdis\/154.4.551","volume":"154","author":"Z Jezek","year":"1986","unstructured":"Jezek Z, Marennikova SS, Mutumbo M, Nakano JH, Paluku KM, Szczeniowski M. Human monkeypox: a study of 2,510 contacts of 214 patients. J Infect Dis. 1986;154(4):551\u20135.","journal-title":"J Infect Dis"},{"issue":"37","key":"7900_CR36","doi-asserted-by":"publisher","first-page":"16262","DOI":"10.1073\/pnas.1005769107","volume":"14","author":"AW Rimoin","year":"2010","unstructured":"Rimoin AW, Mulembakani PM, Johnston SC, Lloyd Smith JO, Kisalu NK, Kinkela TL, et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci USA. 2010;14(37):16262\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"7900_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/00005792-195602000-00002","volume":"35","author":"HJ Magnuson","year":"1956","unstructured":"Magnuson HJ, Thomas EW, Olansky S, Kaplan BI, De Mello L, Cutler JC. Inoculation syphilis in human volunteers. Medicine (Baltimore). 1956;35(1):33\u201382.","journal-title":"Medicine (Baltimore)"},{"key":"7900_CR38","doi-asserted-by":"crossref","unstructured":"Tan DHS, Jaeranny S, Li M, Sukhdeo SS, Monge JC, Callejas MF, et al. Atypical clinical presentation of monkeypox complicated by myopericarditis. Open Forum Infect Dis. 2022;ofac394.","DOI":"10.1093\/ofid\/ofac394"},{"issue":"12","key":"7900_CR39","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1086\/498155","volume":"41","author":"RA Weinstein","year":"2005","unstructured":"Weinstein RA, Nalca A, Rimoin AW, Bavari S, Whitehouse CA. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clin Infect Dis. 2005;41(12):1765\u201371.","journal-title":"Clin Infect Dis."},{"issue":"1","key":"7900_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.0303-6987.2005.00254.x","volume":"32","author":"IB Bayer-Garner","year":"2005","unstructured":"Bayer-Garner IB. Monkeypox virus: histologic, immunohistochemical and electron-microscopic findings. J Cutan Pathol. 2005;32(1):28\u201334.","journal-title":"J Cutan Pathol."},{"issue":"2","key":"7900_CR41","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cid\/cit703","volume":"58","author":"AM McCollum","year":"2014","unstructured":"McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis. 2014;58(2):260\u20137.","journal-title":"Clin Infect Dis."},{"issue":"28","key":"7900_CR42","doi-asserted-by":"publisher","first-page":"904","DOI":"10.15585\/mmwr.mm7128e1","volume":"71","author":"TA Aden","year":"2022","unstructured":"Aden TA, Blevins P, York SW, Rager S, Balachandran D, Hutson CL, et al. Rapid Diagnostic Testing for response to the Monkeypox Outbreak - Laboratory Response Network, United States, May 17-June 30, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(28):904\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"7900_CR43","doi-asserted-by":"crossref","unstructured":"Sukhdeo SS, Aldhaheri K, Lam PW, Walmsley S. A case of human monkeypox in Canada. CMAJ Can Med Assoc J J Assoc Med Can. 2022;cmaj.220886.","DOI":"10.1503\/cmaj.220886"},{"issue":"20","key":"7900_CR44","doi-asserted-by":"publisher","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","volume":"79","author":"G Yang","year":"2005","unstructured":"Yang G, Pevear DC, Davies MH, Collett MS, Bailey T, Rippen S, et al. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge. J Virol. 2005;79(20):13139\u201349.","journal-title":"J Virol"},{"issue":"8","key":"7900_CR45","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1177\/135965350701200802","volume":"12","author":"S Duraffour","year":"2007","unstructured":"Duraffour S, Snoeck R, de Vos R, van Den Oord JJ, Crance JM, Garin D, et al. Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft cultures. Antivir Ther. 2007;12(8):1205\u201316.","journal-title":"Antivir Ther"},{"key":"7900_CR46","unstructured":"Tecovirimat Capsules\u2014Product Monograph. 2020;28."},{"issue":"9","key":"7900_CR47","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/infdis\/jis510","volume":"206","author":"ER Lederman","year":"2012","unstructured":"Lederman ER, Davidson W, Groff HL, Smith SK, Warkentien T, Li Y, et al. Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001. J Infect Dis. 2012;206(9):1372\u201385.","journal-title":"J Infect Dis."},{"issue":"6","key":"7900_CR48","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1016\/S1473-3099(18)30788-6","volume":"19","author":"KM Chan-Tack","year":"2019","unstructured":"Chan-Tack KM, Harrington PR, Choi SY, Myers L, O\u2019Rear J, Seo S, et al. Assessing a drug for an eradicated human disease: US Food and Drug Administration review of tecovirimat for the treatment of smallpox. Lancet Infect Dis. 2019;19(6):e221-4.","journal-title":"Lancet Infect Dis."},{"issue":"1","key":"7900_CR49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMoa1705688","volume":"5","author":"DW Grosenbach","year":"2018","unstructured":"Grosenbach DW, Honeychurch K, Rose EA, Chinsangaram J, Frimm A, Maiti B, et al. Oral Tecovirimat for the treatment of Smallpox. N Engl J Med. 2018;5(1):44\u201353.","journal-title":"N Engl J Med"},{"issue":"2","key":"7900_CR50","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1073\/pnas.0912134107","volume":"107","author":"DW Grosenbach","year":"2010","unstructured":"Grosenbach DW, Berhanu A, King DS, Mosier S, Jones KF, Jordan RA, et al. Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice. Proc Natl Acad Sci USA. 2010;107(2):838\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"7900_CR51","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.1128\/JVI.03426-12","volume":"87","author":"M Zaitseva","year":"2013","unstructured":"Zaitseva M, Shotwell E, Scott J, Cruz S, King LR, Manischewitz J, et al. Effects of postchallenge administration of ST-246 on dissemination of IHD-J-Luc vaccinia virus in normal mice and in immune-deficient mice reconstituted with T cells. J Virol. 2013;87(10):5564\u201376.","journal-title":"J Virol"},{"issue":"14","key":"7900_CR52","doi-asserted-by":"publisher","first-page":"509","DOI":"10.15585\/mmwr.mm7114a1","volume":"71","author":"AK Rao","year":"2022","unstructured":"Rao AK, Schulte J, Chen TH, Hughes CM, Davidson W, Neff JM, et al. Monkeypox in a traveler returning from Nigeria\u2014Dallas, Texas, July 2021. Morb Mortal Wkly Rep. 2022;71(14):509\u201316.","journal-title":"Morb Mortal Wkly Rep."},{"issue":"8","key":"7900_CR53","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","volume":"22","author":"H Adler","year":"2022","unstructured":"Adler H, Gould S, Hine P, Snell LB, Wong W, Houlihan CF, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022;22(8):1153\u201362.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"7900_CR54","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.vaccine.2019.10.049","volume":"38","author":"AT Russo","year":"2020","unstructured":"Russo AT, Berhanu A, Bigger CB, Prigge J, Silvera PM, Grosenbach DW, et al. Co-administration of tecovirimat and ACAM2000TM in non-human primates: effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge. Vaccine. 2020;38(3):644\u201354.","journal-title":"Vaccine."},{"issue":"11","key":"7900_CR55","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1128\/AAC.00762-07","volume":"51","author":"DC Quenelle","year":"2007","unstructured":"Quenelle DC, Prichard MN, Keith KA, Hruby DE, Jordan R, Painter GR, et al. Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses. Antimicrob Agents Chemother. 2007;51(11):4118\u201324.","journal-title":"Antimicrob Agents Chemother"},{"key":"7900_CR56","unstructured":"Prescribing Information for Brincidofovir, FDA 2021 [Internet]. 2021. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/214460s000,214461s000lbl.pdf."},{"issue":"2","key":"7900_CR57","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.virol.2003.11.015","volume":"20","author":"RM Buller","year":"2004","unstructured":"Buller RM, Owens G, Schriewer J, Melman L, Beadle JR, Hostetler KY. Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model. Virology. 2004;20(2):474\u201381.","journal-title":"Virology"},{"issue":"3","key":"7900_CR58","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0166-3542(03)00110-4","volume":"59","author":"SL Ciesla","year":"2003","unstructured":"Ciesla SL, Trahan J, Wan WB, Beadle JR, Aldern KA, Painter GR, et al. Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney. Antiviral Res. 2003;59(3):163\u201371.","journal-title":"Antiviral Res"},{"issue":"1","key":"7900_CR59","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.antiviral.2007.08.003","volume":"77","author":"S Parker","year":"2008","unstructured":"Parker S, Touchette E, Oberle C, Almond M, Robertson A, Trost LC, et al. Efficacy of therapeutic intervention with an oral ether-lipid analogue of cidofovir (CMX001) in a lethal mousepox model. Antiviral Res. 2008;77(1):39\u201349.","journal-title":"Antiviral Res."},{"key":"7900_CR60","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.antiviral.2015.02.007","volume":"117","author":"LC Trost","year":"2015","unstructured":"Trost LC, Rose ML, Khouri J, Keilholz L, Long J, Godin SJ, et al. The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: a model of smallpox disease. Antiviral Res. 2015;117:115\u201321.","journal-title":"Antiviral Res"},{"issue":"2","key":"7900_CR61","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.bbmt.2018.09.038","volume":"25","author":"FM Marty","year":"2019","unstructured":"Marty FM, Winston DJ, Chemaly RF, Mullane KM, Shore TB, Papanicolaou GA, et al. A Randomized, Double-Blind, placebo-controlled phase 3 trial of oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2019;25(2):369\u201381.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"7900_CR62","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.antiviral.2017.01.009","volume":"143","author":"G Chittick","year":"2017","unstructured":"Chittick G, Morrison M, Brundage T, Nichols WG. Short-term clinical safety profile of brincidofovir: a favorable benefit-risk proposition in the treatment of smallpox. Antiviral Res. 2017;143:269\u201377.","journal-title":"Antiviral Res"},{"key":"7900_CR63","unstructured":"ACAM2000\u2014Prescribing Information [Internet]. FDA; 2018. Available from: https:\/\/www.fda.gov\/files\/vaccines%2C%20blood%20%26%20biologics\/published\/Package-Insert---ACAM2000.pdf."},{"issue":"Suppl 2","key":"7900_CR64","first-page":"31","volume":"8","author":"TP Monath","year":"2004","unstructured":"Monath TP, Caldwell JR, Mundt W, Fusco J, Johnson CS, Buller M, et al. ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)\u2014a second-generation smallpox vaccine for biological defense. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2004;8(Suppl 2):31\u201344.","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"issue":"10","key":"7900_CR65","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.vaccine.2008.11.079","volume":"27","author":"SE Frey","year":"2009","unstructured":"Frey SE, Newman FK, Kennedy JS, Ennis F, Abate G, Hoft DF, et al. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and dryvax in healthy vaccinia-naive adults. Vaccine. 2009;27(10):1637\u201344.","journal-title":"Vaccine."},{"issue":"2","key":"7900_CR66","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1086\/375824","volume":"37","author":"VA Fulginiti","year":"2003","unstructured":"Fulginiti VA, Papier A, Lane JM, Neff JM, Henderson DA, et al. Smallpox vaccination: a review, Part I. Background, vaccination technique, normal vaccination and revaccination, and expected normal reactions. Clin Infect Dis. 2003;37(2):241\u201350.","journal-title":"Clin Infect Dis."},{"issue":"6","key":"7900_CR67","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1001\/archdermatol.2010.46","volume":"146","author":"TM Beachkofsky","year":"2010","unstructured":"Beachkofsky TM, Carrizales SC, Bidinger JJ, Hrncir DE, Whittemore DE, Hivnor CM. Adverse events following smallpox vaccination with ACAM2000 in a military population. Arch Dermatol. 2010;146(6):656\u201361.","journal-title":"Arch Dermatol."},{"issue":"37","key":"7900_CR68","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1016\/j.vaccine.2014.06.034","volume":"32","author":"MM McNeil","year":"2014","unstructured":"McNeil MM, Cano M, Miller R, Petersen E, Engler BW, Bryant-Genevier RJM. Ischemic cardiac events and other adverse events following ACAM2000(\u00ae) smallpox vaccine in the vaccine adverse event reporting system. Vaccine. 2014;32(37):4758\u201365.","journal-title":"Vaccine."},{"issue":"39","key":"7900_CR69","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1016\/j.vaccine.2021.08.041","volume":"15","author":"MD Decker","year":"2021","unstructured":"Decker MD, Garman PM, Hughes H, Yacovone MA, Collins LC, Fegley CD, et al. Enhanced safety surveillance study of ACAM2000 smallpox vaccine among US military service members. Vaccine. 2021;15(39):5541\u20137.","journal-title":"Vaccine"},{"key":"7900_CR70","unstructured":"imvanex-epar-product-information_en.pdf [Internet]. [cited 2022 Aug 9]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/imvanex-epar-product-information_en.pdf."},{"key":"7900_CR71","unstructured":"00063755.pdf [Internet]. [cited 2022 Aug 9]. Available from: https:\/\/pdf.hres.ca\/dpd_pm\/00063755.PDF."},{"issue":"20","key":"7900_CR72","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1056\/NEJMoa1817307","volume":"14","author":"PR Pittman","year":"2019","unstructured":"Pittman PR, Hahn M, Lee HS, Koca C, Samy N, Schmidt D, et al. Phase 3 efficacy trial of modified Vaccinia Ankara as a vaccine against Smallpox. N Engl J Med. 2019;14(20):1897\u2013908.","journal-title":"N Engl J Med"},{"key":"7900_CR73","unstructured":"Product Monograph\u2014Imvamune [Internet]. 2020. Available from: https:\/\/pdf.hres.ca\/dpd_pm\/00058622.PDF."},{"key":"7900_CR74","unstructured":"CDC. Monkeypox in the U.S. Interim Considerations [Internet]. Centers for Disease Control and Prevention. 2022 [cited 2022 Aug 17]. Available from: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/interim-considerations\/overview.html."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07900-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07900-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07900-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T02:05:05Z","timestamp":1671069905000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07900-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7900"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07900-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"22 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"928"}}